Get the Stockscreener App
1.25
4.58%
-0.06
Exicure Inc stock is traded at $1.25, with a volume of 21,775.
It is down -4.58% in the last 24 hours and down -27.33% over the past month.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
See More
Previous Close:
$1.31
Open:
$1.33
24h Volume:
21,775
Relative Volume:
0.06
Market Cap:
$7.97M
Revenue:
$500.00K
Net Income/Loss:
$-9.78M
P/E Ratio:
-0.8107
EPS:
-1.5419
Net Cash Flow:
$-8.10M
1W Performance:
-7.06%
1M Performance:
-27.33%
6M Performance:
-69.36%
1Y Performance:
-81.75%
1-Day Range:
$1.25
$1.33
1-Week Range:
$1.18
$1.4399
52-Week Range:
$1.18
$9.4799
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847-673-1707
Address
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView
Exicure Deadline Alert - TMX Newsfile
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Inc (XCUR) Stock News Today - tradingkey.com
XCUR|Exicure Inc|Price:1.345|Chg%:-0.010 - tradingkey.com
Trading Systems Reacting to (XCUR) Volatility - Stock Traders Daily
Exicure Shareholder Alert - TMX Newsfile
XCUR Looks 231.6% Overvalued on GF Value™ - GuruFocus
Exicure to issue shares to settle $1M clinical milestone payment - Investing.com
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - The Manila Times
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative
Exicure to settle $1M clinical milestone with G... - pluang.com
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Exicure Inc (XCUR) Cash Flow - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Balance Sheet - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XCUR|Exicure Inc|Price:1.330|Chg%:-0.180 - TradingKey
XCUR|Exicure Inc|Price:1.760|Chg%:+0.050 - TradingKey
Exicure Inc (XCUR) Income Statement - TradingKey
Exicure, Inc. Revenue Breakdown – NASDAQ:XCUR - TradingView
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XCUR stock trades on limited evidence as Exicure waits for filings - Ad-hoc-news.de
XCUR|Exicure Inc|Price:1.700|Chg%:-0.010 - TradingKey
Form 4 Exicure Inc For: 17 July By Investing.com - Investing.com Nigeria
Form 13D/A EXICURE For: 17 July By Investing.com - Investing.com Nigeria
Exicure, Inc. (XCUR) holder Exicure HiTron regains 623,275 returned shares - Stock Titan
Exicure HiTron boosts Exicure (XCUR) holding to 2.22M shares, 34.87% - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Trending Stocks Today | Exicure Shoots up 31.39% Post-Market - Moomoo
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Exicure Inc. (XCUR) Q2 2022 Earnings: Significant Earnings Miss and Negative Stock ReactionEarnings Sentiment Score - dars.gov.et
How Exicure Inc. (XCUR) Affects Rotational Strategy Timing - Stock Traders Daily
Stock Market News: Ethan Allen Interiors down by 90.10% while Exicure gains 99.48% during mid day trading - Business Upturn
Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under ScrutinyVolatility Skew - dars.gov.et
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Drives Double-Digit DeclineFree Cash Flow Trends - dars.gov.et
Exicure stock holds its line. Company context stays front and center. - Ad-hoc-news.de
Debt to assets ratio of Exicure, Inc. – DUS:2H0 - TradingView
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0 - TradingView
Enterprise value to EBITDA forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure stock leans on its cash position. Nasdaq listing keeps it visible. - Ad-hoc-news.de
(XCUR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Exicure refreshes board with new independent directors - The Globe and Mail
New directors join Exicure (NASDAQ: XCUR) board as compensation committee forms - Stock Titan
Exicure announces board changes, adds two new directors By Investing.com - Investing.com Nigeria
Exicure announces board changes, adds two new directors - Investing.com
Press Release: Exicure Announces Board and Committee Changes - Moomoo
Exicure Announces Board and Committee Changes - The Manila Times
Exicure expands board to 6, names 2 new directors - Stock Titan
Exicure Inc Stock (XCUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):